论文部分内容阅读
目的:比较慢性胃炎应用抗菌疗法与一般疗法的效果。方法:纳入20例慢性胃炎患者,以入院顺序分为对照组,予以普托平(兰索拉唑)+膜固思达(瑞巴派特)连服8周;观察组先行普托平+左氧氟沙星+甲硝唑2周后改用对照组药物6周。结果:观察组症状总有效率50%,对照组20%,胃黏膜慢性炎症、活动性炎症观察组分别50%、70%;对照组20%、20%。结论:慢性胃炎同时先行抗菌疗法治疗后抑酸保护胃黏膜治疗比单纯抑酸及保护胃黏膜效果好。目前世界上约有50%的人携带Hp,这种微生物被认为是胃部微生物的一部分。近年日趋成熟的基因测序和微生物组学技术已证实,除了Hp外,胃内还存在着其他微生物群落和菌群结构,一旦胃内微生态混乱,或某一菌群超出正常范围,则可致病[1]。本文研究采用抗菌疗法及常规疗法治疗慢性胃炎的疗效对比研究,现报告如下。
OBJECTIVE: To compare the effects of antimicrobial therapy and general therapies for chronic gastritis. Methods: Twenty patients with chronic gastritis were enrolled in this study. Patients were divided into control group on the order of admission, and treated with Putopine (Lansoprazole) + Membranous Starburst (Rebamipide) for 8 weeks. The observation group was treated with Putopin + Levofloxacin + metronidazole 2 weeks after the switch to the control group of drugs for 6 weeks. Results: The total effective rate was 50% in the observation group, 20% in the control group, chronic inflammation of the gastric mucosa, 50% in the active inflammation group, 70% in the observation group and 20% in the control group. CONCLUSION: Gastric mucosa treated with acid-fast gastric acid therapy is superior to acid-only therapy and gastric mucosal protection. Approximately 50% of the world’s population currently carries Hp, which is thought to be part of the stomach’s micro-organism. In recent years, more and more mature gene sequencing and microbiology techniques have confirmed that, in addition to Hp, there are still other stomach microbial community and flora structure, once the stomach micro-ecological disorders, or a group of bacteria beyond the normal range, it can be caused Disease [1]. This article studies the use of antimicrobial therapy and conventional therapies for the treatment of chronic gastritis comparative study, are as follows.